ImmunityBio Aktie

2,57 EUR -0,07 EUR -2,54 %

04.04.2025

STU

2,79 USD -0,04 USD -1,41 %

nachbörslich04.04.2025

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.2,20 Mrd. EUR

Div. Rendite0,00%

WKNA2QQ2E

ISINUS45256X1037

SymbolIBRX

ImmunityBio Aktien News

Sortieren:Datum Meistgelesen

06.03.25BenzingaImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug

03.03.25ZacksImmunityBio (IBRX) Reports Q4 Loss, Misses Revenue Estimates

20.01.25BenzingaIonQ, H&E Equipment Services And ImmunityBio Are Among Top Mid Cap Gainers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?

WerbungImmunityBio-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

16.01.25BenzingaImmunityBio Stock Trading Higher On Updates From Bladder Cancer Trials: Details

11.12.24BenzingaWhat's Going On With ImmunityBio Shares Wednesday?

21.11.24PR NewswireImmunityBio and nCartes Enter Collaboration Agreement on Clinical Trial Data Fulfillment

19.11.24ZacksWall Street Analysts Think ImmunityBio (IBRX) Could Surge 184.43%: Read This Before Placing a Bet

19.11.24PR NewswireImmunityBio, Inc. Investor Alert (NASDAQ: IBRX): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors for Possible False Statements

12.11.24ZacksImmunityBio (IBRX) Reports Q3 Loss, Tops Revenue Estimates

28.10.24ZacksImmunityBio (IBRX) Soars 26.4%: Is Further Upside Left in the Stock?

27.10.24BenzingaTrump Media & Tech, ImmunityBio, And iRhythm Are Among Top 10 Mid Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?

23.10.24Benzinga800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio

11.10.24PR NewswireIMMUNITYBIO INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ImmunityBio, Inc. - IBRX

12.08.24ZacksImmunityBio (IBRX) Reports Q2 Loss, Lags Revenue Estimates

26.06.24ZacksImmunityBio (IBRX) Gains 17% in the Past Week: Here's Why

20.06.24BenzingaWhy ImmunityBio Stock Is Trading Higher Thursday

28.08.23PR NewswireSHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 29, 2023 in the Class Action Filed on Behalf of ImmunityBio, Inc. (IBRX) Shareholders

18.08.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ImmunityBio, Inc. of Class Action Lawsuit and Upcoming Deadline - IBRX

15.08.23PR NewswireIBRX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 29, 2023 in the Class Action Filed on Behalf of ImmunityBio, Inc. Shareholders

14.08.23PR NewswireROSEN, A LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors with Losses to Secure Counsel Before Important August 29 Deadline in Securities Class Action - IBRX

14.08.23PR NewswireSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating ImmunityBio, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

10.08.23PR NewswireIBRX LAWSUIT ALERT: Levi & Korsinsky Notifies ImmunityBio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

04.08.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ImmunityBio, Inc. of Class Action Lawsuit and Upcoming Deadline - IBRX

31.07.23PR NewswireIBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit

28.07.23PR NewswireIBRX SHAREHOLDER ALERT: Jakubowitz Law Reminds ImmunityBio Shareholders of a Lead Plaintiff Deadline of August 29, 2023

27.07.23PR NewswireIBRX LAWSUIT ALERT: Levi & Korsinsky Notifies ImmunityBio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

25.07.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ImmunityBio, Inc. of Class Action Lawsuit and Upcoming Deadline - IBRX

21.07.23PR NewswireIBRX SHAREHOLDER ALERT: Jakubowitz Law Reminds ImmunityBio Shareholders of a Lead Plaintiff Deadline of August 29, 2023

12.07.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ImmunityBio, Inc. of Class Action Lawsuit and Upcoming Deadline - IBRX

05.07.23PR NewswireCalling All ImmunityBio, Inc. (IBRX) Investors: Contact Bronstein, Gewirtz & Grossman, LLC Today!

19.05.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX

ImmunityBio News

ImmunityBio News: auf dieser Seite finden Sie alle ImmunityBio News und Nachrichten zur ImmunityBio Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch ImmunityBio News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um ImmunityBio News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.